Montelukast for bronchiolitis obliterans syndrome after lung transplantation: A randomized controlled trial

Bronchiolitis obliterans syndrome (BOS) remains the major problem which precludes long-term survival after lung transplantation. Previously, an open label pilot study from our group demonstrated a possible beneficial effect of montelukast in progressive BOS patients with low airway neutrophilia (<...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:PLoS One
Egile Nagusiak: Ruttens, David, Verleden, Stijn E., Demeyer, Heleen, Van Raemdonck, Dirk E., Yserbyt, Jonas, Dupont, Lieven J., Vanaudenaerde, Bart M., Vos, Robin, Verleden, Geert M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Public Library of Science 2018
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5889063/
https://ncbi.nlm.nih.gov/pubmed/29624575
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0193564
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak